The Effect Of Blood Flow Restrıcted Resistive And Aerobic Exercises in Chronic Obstructive Pulmonary Patients
COPD
1 other identifier
interventional
40
1 country
1
Brief Summary
Patients with chronic obstructive pulmonary disease (COPD) classified by a pulmonologist in accordance with the GOLD criteria will be randomly divided into 2 groups. The first group (n = 20) was accompanied by blood flow restriction (CAC), 3 times a week, 8 weeks, 1RMx 30% intensity, 10 repetitions, 3 sets, 30 seconds rest interval, progressive resistance exercise (PRE) and after 5 minutes of rest by cycling. Progressive aerobic exercise (AE) (BFR PRE + AE group) in the target heart rate range of 50-80% intensity will be applied to the second group (n = 20), PRE and AE (PRE + AE group) performed at the same intensity and duration without BFR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2020
CompletedStudy Start
First participant enrolled
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
August 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2021
CompletedApril 16, 2025
April 1, 2025
6 months
August 18, 2020
April 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
FEV1/FVC rate
respiratory function test
eight weeks
creatine kinase
muscle breakdown marker
eight weeks
c reactive protein
thrombus formation risk marker
eight weeks
d-dimer
venous thromboembolism marker
eight weeks
total antioxidant status
oxidative stress marker
eight weeks
total oxidant status
oxidative stress marker
eight weeks
interleukin 6
inflammation marker
eight weeks
oxygen saturation
blood gas test
three times a week
heart rate
for exercise dose determination
three times a week
six minute walk test
strength evaluation
eight weeks
ST george's respiratory questionnaire
used to evaluate the effects of respiratory disease's symptoms and illness
eight weeks
quadriceps muscle diameter
Measurement of change in muscle volume
eight weeks
Study Arms (2)
Blood Flow Restricted Aerobic and Resistance Exercise Group
ACTIVE COMPARATORkan akımı kısıtlanarak.direnç ve bisikletle aerobik egzersiz uygulanacak
Normal aerobik ve direnç egzersiz grubu
ACTIVE COMPARATORNormal şartlarda aerobik ve direnç egzersizi uygulanacak
Interventions
Interventions of the same duration and intensity will be applied to two groups.
Eligibility Criteria
You may qualify if:
- Being diagnosed with mild to severe COPD according to GOLD criteria in the age range of 40-78
- No drug change for at least 30 days
- Not participating in a structured activity program for at least six months
- Have the ability to cooperate.
You may not qualify if:
- Presence of any pathology that limits physical activity performance
- Presence of severe or unstable heart disease
- Presence of peripheral artery disease
- Being in an exacerbation period of the disease
- Presence of another active disease (rheumatic, oncological, traumatic etc.)
- Any neurological or orthopedic disease that prevents exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karabük Üniversitesi Araştırma Hastanesi Göğüs Hastalıkları Kliniği
Karabük, Karabük Province, 78600, Turkey (Türkiye)
Related Publications (8)
Patterson SD, Hughes L, Warmington S, Burr J, Scott BR, Owens J, Abe T, Nielsen JL, Libardi CA, Laurentino G, Neto GR, Brandner C, Martin-Hernandez J, Loenneke J. Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Front Physiol. 2019 May 15;10:533. doi: 10.3389/fphys.2019.00533. eCollection 2019.
PMID: 31156448BACKGROUNDNolan CM, Rochester CL. Exercise Training Modalities for People with Chronic Obstructive Pulmonary Disease. COPD. 2019 Dec;16(5-6):378-389. doi: 10.1080/15412555.2019.1637834. Epub 2019 Nov 4.
PMID: 31684769BACKGROUNDScott BR, Loenneke JP, Slattery KM, Dascombe BJ. Exercise with blood flow restriction: an updated evidence-based approach for enhanced muscular development. Sports Med. 2015 Mar;45(3):313-25. doi: 10.1007/s40279-014-0288-1.
PMID: 25430600BACKGROUNDKacin A, Strazar K. Frequent low-load ischemic resistance exercise to failure enhances muscle oxygen delivery and endurance capacity. Scand J Med Sci Sports. 2011 Dec;21(6):e231-41. doi: 10.1111/j.1600-0838.2010.01260.x. Epub 2011 Mar 8.
PMID: 21385216BACKGROUNDLoenneke JP, Allen KM, Mouser JG, Thiebaud RS, Kim D, Abe T, Bemben MG. Blood flow restriction in the upper and lower limbs is predicted by limb circumference and systolic blood pressure. Eur J Appl Physiol. 2015 Feb;115(2):397-405. doi: 10.1007/s00421-014-3030-7. Epub 2014 Oct 22.
PMID: 25338316BACKGROUNDWilson JM, Lowery RP, Joy JM, Loenneke JP, Naimo MA. Practical blood flow restriction training increases acute determinants of hypertrophy without increasing indices of muscle damage. J Strength Cond Res. 2013 Nov;27(11):3068-75. doi: 10.1519/JSC.0b013e31828a1ffa.
PMID: 23446173BACKGROUNDBerzosa C, Cebrian I, Fuentes-Broto L, Gomez-Trullen E, Piedrafita E, Martinez-Ballarin E, Lopez-Pingarron L, Reiter RJ, Garcia JJ. Acute exercise increases plasma total antioxidant status and antioxidant enzyme activities in untrained men. J Biomed Biotechnol. 2011;2011:540458. doi: 10.1155/2011/540458. Epub 2011 Mar 9.
PMID: 21436993BACKGROUNDWilk M, Krzysztofik M, Gepfert M, Poprzecki S, Golas A, Maszczyk A. Technical and Training Related Aspects of Resistance Training Using Blood Flow Restriction in Competitive Sport - A Review. J Hum Kinet. 2018 Dec 31;65:249-260. doi: 10.2478/hukin-2018-0101. eCollection 2018 Dec.
PMID: 30687436BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- 40 COPD patients will be randomised divided into two equal groups according to age, gender and disease severity.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
August 18, 2020
First Posted
August 21, 2020
Study Start
August 19, 2020
Primary Completion
February 23, 2021
Study Completion
May 25, 2021
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share